Exclusive

Publication

Byline

Location

US Patent Issued to International AIDS Vaccine Initiative, The Scripps Research Institute on April 21 for "Immunogenic trimers" (California, New York Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,441, issued on April 21, was assigned to International AIDS Vaccine Initiative Inc. (New York) and The Scripps Research Institute (La Jolla... Read More


US Patent Issued to Colorado State University Research Foundation, Dynavax Technologies on April 21 for "Production of vaccines comprising inactivated SARS-CoV-2 viral particles" (Colorado Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,442, issued on April 21, was assigned to Colorado State University Research Foundation (Fort Collins, Colo.) and Dynavax Technologies Corp.... Read More


US Patent Issued to The Government of the United States, as Represented by the Secretary of the Army on April 21 for "SAR-CoV-2 DNA vaccine and method of administering thereof" (Maryland Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,443, issued on April 21, was assigned to The Government of the United States, as Represented by the Secretary of the Army (Fort Detrick, Md... Read More


US Patent Issued to Virion Therapeutics, The Wistar Institute on April 21 for "Adenoviral vectors encoding hepatitis B viral antigens fused to herpes virus glycoprotein D and methods of using the same" (California, Pennsylvania Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,444, issued on April 21, was assigned to Virion Therapeutics LLC (Newark, Del.) and The Wistar Institute (Philadelphia). "Adenoviral vecto... Read More


US Patent Issued to University of Florida Research Foundation on April 21 for "Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancer" (Florida Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,445, issued on April 21, was assigned to University of Florida Research Foundation Inc. (Gainesville, Fla.). "Hematopoietic stem cells in ... Read More


US Patent Issued to The Methodist Hospital on April 21 for "PSMA-targeted immunotherapies for cancers" (Texas Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,446, issued on April 21, was assigned to The Methodist Hospital (Houston). "PSMA-targeted immunotherapies for cancers" was invented by Bin... Read More


US Patent Issued to ITM Solucin on April 21 for "Stable formulations for radionuclide complexes" (German, Italian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,447, issued on April 21, was assigned to ITM Solucin GmbH (Garching bei Munchen, Germany). "Stable formulations for radionuclide complexes... Read More


US Patent Issued to REGENTS OF THE UNIVERSITY OF MICHIGAN on April 21 for "Porous self-healing polymer matrix for encapsulation of active macromolecules and methods" (Michigan, New Jersey Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,448, issued on April 21, was assigned to REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Mich.). "Porous self-healing polymer matrix for... Read More


US Patent Issued to Korea Institute of Geoscience and Mineral Resources on April 21 for "Drug-clay mineral complex containing phospholipid and oral administration composition including same" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,449, issued on April 21, was assigned to Korea Institute of Geoscience and Mineral Resources (Daejeon, South Korea). "Drug-clay mineral co... Read More


US Patent Issued to C4 THERAPEUTICS on April 21 for "C3-carbon linked glutarimide Degronimers for target protein degradation" (Colorado, Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,450, issued on April 21, was assigned to C4 THERAPEUTICS INC. (Watertown, Mass.). "C3-carbon linked glutarimide Degronimers for target pro... Read More